You searched for "complaints"

1456 results found

The College of Optometrists publishes updated Clinical Governance Guidance to support quality improvement and excellence in optometry

The College of Optometrists has launched its updated Clinical Governance Guidance to provide members with a robust framework that aligns with the healthcare landscape and primary care optometry workplace practices of today - and into the future. The guidance will...

Green Charter inspires the Optical Community

Green Charter – the optical community’s clear pathway for a sustainable future – attracted great interest at 100% Optical, with businesses keen to learn more about specific guidance. Launched by Opticare Innovations, the commercial arm of the OSA, the five...

Glaucoma medications and ocular surface disease

This literature review examined ocular surface disease (OSD) associated with glaucoma medication. The authors examined the prevalence of features and management guidelines glaucoma medication associated OSD. Fifty-eight articles published within the past five years are included in this review and...

Oertli Instrumente AG achieves milestone with FDA 510(k) clearance for Faros surgical system

Oertli Instrumente AG, a leader in innovative surgical solutions for ophthalmology, is proud to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance for the worldwide established Faros anterior cataract surgery system. This milestone underscores Oertli's global reach and...

Introducing the Surgitrac Information Hub: A New Resource for Ophthalmic Professionals

Finding reliable, practical information in ophthalmology should not feel difficult. That is why Surgitrac has launched its brand-new Information Hub, a dedicated online resource designed to support surgeons, theatre teams, nurses and procurement professionals with trusted educational content and essential...

Management of diabetic macular oedema in vitrectomised eyes

Diabetic macular oedema (DMO) is one of the leading causes of blindness; its prevalence is on the rise with progressive increase in numbers of people suffering from diabetes. The management of DMO has evolved significantly over the past few years....

The fragile p-value

Abdus Samad Ansari explores the limitation of the p-value and the application of the fragility index in clinical trials. Clinical trials and tribulations? The restoration of vision or more purely the gift of sight is an aspect of care that...

Real-world experience and outcomes of SLT laser used as a first-line treatment in ocular hypertension patients in a United Kingdom National Health Service setting

The management of raised intraocular pressure (IOP) in the context of ocular hypertension (OHT) and primary open angle glaucoma (POAG) remains a major contributor to the workload of ophthalmology units across the UK. Treatment of these conditions has historically centred...

Vitreoretinal Disease: Diagnosis, Management and Clinical Pearls (second edition)

A comprehensive, well-illustrated and highly informative resource providing excellent descriptions of vitreoretinal diseases, their presentation, diagnosis and management. The 40 chapters are grouped into four sections, namely: the Anatomy and Physiology of the vitreous, retina, choroid and retinal pigment epithelium;...

Exploring the potential of neurodegenerative disease screening within age-related eye disease research

The authors recruited healthy controls aged between 60 and 75-years-old, previously enrolled into a registry as patients following cataract surgery without age-related macular degeneration (AMD). Exclusion criteria included dense cataract, retinal disease, ocular inflammatory disease, moderate glaucoma, optic neuropathy, cancer,...

Could idebenone by the solution for treating dominant optic atrophy?

Dominant optic atrophy (DOA) is a disease of the retinal ganglion cells, with no current treatment options. In most cases, DOA is caused by a mutation in the OPA1 gene. The aim of this study was to evaluate the effect...

OrCam MyEye – innovative sight assistance (Part 1)

For Jun/Jul 20201 and Aug/Sep 2021 we have a two-part review (see Part 2 here) of an innovative piece of sight impairment technology. The device is called a MyEye, made by OrCam. I was given the opportunity to use the...